Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q5342173> ?p ?o }
Showing triples 1 to 42 of
42
with 100 triples per page.
- Q5342173 description "American chemist".
- Q5342173 description "American chemist".
- Q5342173 subject Q5312304.
- Q5342173 subject Q5660469.
- Q5342173 subject Q6368932.
- Q5342173 subject Q6647258.
- Q5342173 subject Q7003098.
- Q5342173 subject Q7453817.
- Q5342173 subject Q8883387.
- Q5342173 abstract "Edward Curtis Taylor, Jr. (born August 3, 1923)) is an American chemist who designed and synthesized the chemotherapy drug pemetrexed (brand name Alimta), an inhibitor of purine biosynthesis, with grant support from the U.S. National Cancer Institute, NIH. Taylor studied for his PhD from 1946 to 1949 at Cornell University with Professor Cornelius Cain. As of 2009, royalties for this drug from Eli Lilly & Co. paid to Princeton University were sufficient to completely finance a state-of-the-art 263,000-square-foot (24,400 m2) chemistry laboratory building.In 2006 Taylor was named a Hero of Chemistry by the American Chemical Society. Taylor has completed 187 PhD students.".
- Q5342173 birthDate "1923-08-03".
- Q5342173 birthYear "1923".
- Q5342173 wikiPageWikiLink Q21578.
- Q5342173 wikiPageWikiLink Q247556.
- Q5342173 wikiPageWikiLink Q415220.
- Q5342173 wikiPageWikiLink Q5312304.
- Q5342173 wikiPageWikiLink Q5660469.
- Q5342173 wikiPageWikiLink Q6368932.
- Q5342173 wikiPageWikiLink Q6647258.
- Q5342173 wikiPageWikiLink Q7003098.
- Q5342173 wikiPageWikiLink Q728265.
- Q5342173 wikiPageWikiLink Q7453817.
- Q5342173 wikiPageWikiLink Q8883387.
- Q5342173 wikiPageWikiLink Q974135.
- Q5342173 dateOfBirth "1923-08-03".
- Q5342173 name "Taylor, Edward C.".
- Q5342173 shortDescription "American chemist".
- Q5342173 type Person.
- Q5342173 type Agent.
- Q5342173 type Person.
- Q5342173 type Agent.
- Q5342173 type NaturalPerson.
- Q5342173 type Thing.
- Q5342173 type Q215627.
- Q5342173 type Q5.
- Q5342173 type Person.
- Q5342173 comment "Edward Curtis Taylor, Jr. (born August 3, 1923)) is an American chemist who designed and synthesized the chemotherapy drug pemetrexed (brand name Alimta), an inhibitor of purine biosynthesis, with grant support from the U.S. National Cancer Institute, NIH. Taylor studied for his PhD from 1946 to 1949 at Cornell University with Professor Cornelius Cain. As of 2009, royalties for this drug from Eli Lilly & Co.".
- Q5342173 label "Edward C. Taylor".
- Q5342173 givenName "Edward C.".
- Q5342173 name "Edward C. Taylor".
- Q5342173 name "Taylor, Edward C.".
- Q5342173 surname "Taylor".